The growing prevalence of sleep apnea and rapid developments in diagnosis and treatment modalities have boosted the demand for sleep apnea implants significantly. Sleep apnea is a serious sleep disorder characterized by pauses in breathing or instances of shallow or infrequent breathing during sleep. Some common symptoms of sleep apnea include loud snoring, awakening with a gasping sound, morning headaches, morning dry throat and irritability during the day. If left untreated, sleep apnea can raise the risk of serious medical conditions like diabetes, stroke, cardiovascular diseases and depression.
Sleep Apnea Implants Market Demand devices are increasingly used to keep the airway open in patients with moderate to severe forms of obstructive sleep apnea who do not respond well to CPAP therapy or prefer an alternate treatment option. Technological advancements have led to the development of minimally invasive implantable systems that stimulate the muscles to enlarge the airway during sleep. With rising healthcare expenditures on chronic disease management and improved diagnosis rates,
The global Sleep Apnea Implants market is estimated to be worth USD 360.1 Mn in 2024 and is projected to reach USD 907.2 Mn by 2031 , at a compound annual growth rate (CAGR) of 14.1% from 2024 to 2031.
Key Takeaways
Key players operating in the sleep apnea implants market are Inspire Medical Systems, Livanova, Medtronic and Respicardia. Inspire Medical System's sleep apnea treatment system, Inspire therapy which uses neurostimulation of the tongue muscle to open the airway during sleep has gained significant market traction.
The growing penetration of telemedicine and remote patient monitoring solutions have eased access to sleep specialists and diagnostic testing during the Covid-19 pandemic, presenting lucrative opportunities for market players. Several companies are also striving to develop less invasive implantable solutions and new categories of treatments like nerve stimulation to expand the eligible patient pool.
North America currently dominates the global market due to favorable reimbursement policies and growing awareness about sleep disorders. However, emerging regions like Asia Pacific and Latin America are expected to witness highest growth owing to increasing healthcare spending, medical tourism and large undiagnosed patient populations. Market players are actively looking to strengthen their presence in emerging markets through partnerships and strategic acquisitions.
Market drivers
- Rising prevalence of obesity: Weight gain and excess fat deposition in the neck region can narrow the airways and elevate chances of sleep apnea. With global obesity rates rising continuously, the incidence of sleep apnea has surged significantly.
- Growing geriatric population: Risk of sleep apnea increases with age due to weakening of respiratory muscles and alterations in breathing patterns during sleep. Since the elderly constitute the fastest growing demographic globally, it will further propel the demand for sleep apnea implants.
Market restrain
- High cost of implants: Though offering an effective long-term solution, sleep apnea implants involve substantial upfront costs and additional hospitalization charges. Limited health insurance coverage acts as a major restraint for widespread adoption.
Segment Analysis
The sleep apnea implants market can be segmented based on product into mandibular advancement devices, tongue retaining devices, and palatal implants. Among them, the mandibular advancement devices segment holds the largest share as they are the most common and preferred treatment option for mild to moderate obstructive sleep apnea. These devices help enlarge the airway by pushing the lower jaw and tongue forward when a person is sleeping. The palatal implants segment is expected to witness fastest growth during the forecast period due to rising adoption of minimally invasive procedures.
Global Analysis
The North America region currently dominates the sleep apnea implants market owing to rising number of patients being diagnosed with obstructive sleep apnea and availability of advanced treatment options. According to statistical estimates, over 26% of adult population in the United States suffers from sleep apnea. Europe holds the second largest share and is expected to grow at over 12% CAGR through 2031. This can be attributed to increasing awareness and government initiatives promoting treatment of sleep disorders. The Asia Pacific region provides significant growth opportunities for market players due to growing spending on healthcare sector and vast untapped population base in countries like India and China. Growing medical device industry and rising penetration of major players will further boost the regional market over the forecast period.
Get This Report In Japanese Language
Get This Report In Korean Language
About Author:
Vaagisha brings over three years of expertise as a content editor in the market research domain. Originally a creative writer, she discovered her passion for editing, combining her flair for writing with a meticulous eye for detail. Her ability to craft and refine compelling content makes her an invaluable asset in delivering polished and engaging write-ups.
(LinkedIn: https://www.linkedin.com/in/vaagisha-singh-8080b91)
